Advertisement
Screener

ADAGE CAPITAL PARTNERS GP, L.L.C. Historic Quarter Change: Foreign ADRs, New

ADAGE CAPITAL PARTNERS GP, L.L.C. historic quarter change: Foreign ADRs, New

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 24 quarters from 2013-03-31 to 2026-06-30, ADAGE CAPITAL PARTNERS GP, L.L.C. opened 32 positions, added to 13, reduced 14 and sold out of 30.

  • Q1 2025: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR; Shares before 0.
  • Q4 2024: Stock ASTRAZENECA PLC; Country of operation —; Class SPONSORED ADR; Shares before 0.
  • Q2 2024: Stock ASTRAZENECA PLC; Country of operation —; Class SPONSORED ADR; Shares before 0.
  • Q3 2016: Stock ASTRAZENECA PLC; Country of operation —; Class SPONSORED ADR; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1165408), 24 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14); Q2 2013 (2013-03-31 to 2013-06-30, filed 2013-08-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2001-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q1 2025ASCENDIS PHARMA A/S
CUSIP 04351P101
SPONSORED ADR0327,405+327,405$0$51,029,343+$51,029,3432025-05-15
Q4 2024ASTRAZENECA PLC
CUSIP 046353108
SPONSORED ADR0353,438+353,438$0$23,157,258+$23,157,2582025-02-14
Q2 2024ASTRAZENECA PLC
CUSIP 046353108
SPONSORED ADR0346,468+346,468$0$27,021,039+$27,021,0392024-08-14
Q3 2016ASTRAZENECA PLC
CUSIP 046353108
SPONSORED ADR0600,000+600,000$0$19,716,000+$19,716,0002016-11-14
Q3 2016TOTAL S A
CUSIP 89151E109
SPONSORED ADR0110,436+110,436$0$5,268,000+$5,268,0002016-11-14
Q3 2016TRINITY BIOTECH PLC
CUSIP 896438306
SPON ADR NEW097,154+97,154$0$1,284,000+$1,284,0002016-11-14
Q2 2016SIBANYE GOLD LTD
CUSIP 825724206
SPONSORED ADR01,700,000+1,700,000$0$23,154,000+$23,154,0002016-08-15
Q1 2016ROYAL DUTCH SHELL PLC
CUSIP 780259107
SPON ADR B0271,000+271,000$0$13,330,000+$13,330,0002016-05-16
Q1 2016ANGLOGOLD ASHANTI LTD
CUSIP 035128206
SPONSORED ADR0500,000+500,000$0$6,845,000+$6,845,0002016-05-16
Q4 2015ADVANCED ACCELERATOR APPLIC
CUSIP 00790T100
SPONSORED ADS01,229,830+1,229,830$0$38,457,000+$38,457,0002016-02-16
Q4 2015ROYAL DUTCH SHELL PLC
CUSIP 780259206
SPONS ADR A0396,922+396,922$0$18,175,000+$18,175,0002016-02-16
Q4 2015ASTRAZENECA PLC
CUSIP 046353108
SPONSORED ADR020,000+20,000$0$679,000+$679,0002016-02-16
Q3 2015GLAXOSMITHKLINE PLC
CUSIP 37733W105
SPONSORED ADR01,300,000+1,300,000$0$49,985,000+$49,985,0002015-11-16
Q3 2015NATIONAL GRID PLC
CUSIP 636274300
SPON ADR NEW0496,628+496,628$0$34,580,000+$34,580,0002015-11-16
Q2 2015SHIRE PLC
CUSIP 82481R106
SPONSORED ADR028,000+28,000$0$6,762,000+$6,762,0002015-08-14
Q2 2015BIOTIE THERAPIES OYJ
CUSIP 09074D103
SPONSORED ADR0197,300+197,300$0$3,940,000+$3,940,0002015-08-14
Q1 2015FIBRIA CELULOSE S A
CUSIP 31573A109
SP ADR REP COM0252,965+252,965$0$3,574,000+$3,574,0002015-05-15
Q4 2014MINDRAY MEDICAL INTL LTD
CUSIP 602675100
SPON ADR0243,363+243,363$0$6,425,000+$6,425,0002015-02-17
Q4 2014ROYAL DUTCH SHELL PLC
CUSIP 780259107
SPON ADR B076,000+76,000$0$5,287,000+$5,287,0002015-02-17
Q4 2014TRINITY BIOTECH PLC
CUSIP 896438306
SPON ADR NEW010,000+10,000$0$175,000+$175,0002015-02-17
Q3 2014SHIRE PLC
CUSIP 82481R106
SPONSORED ADR03,267,220+3,267,220$0$846,373,000+$846,373,0002014-11-14
Q2 2014CREDIT SUISSE GROUP
CUSIP 225401108
SPONSORED ADR0100,000+100,000$0$2,837,000+$2,837,0002014-08-14
Q1 2014CRITEO S A
CUSIP 226718104
SPONS ADS0100,000+100,000$0$4,055,000+$4,055,0002014-05-15
Q1 2014MINDRAY MEDICAL INTL LTD
CUSIP 602675100
SPON ADR0100,000+100,000$0$3,236,000+$3,236,0002014-05-15
Q4 2013SHIRE PLC
CUSIP 82481R106
SPONSORED ADR050,671+50,671$0$7,159,000+$7,159,0002014-02-14
Q4 2013ROYAL DUTCH SHELL PLC
CUSIP 780259206
SPONS ADR A049,823+49,823$0$3,551,000+$3,551,0002014-02-14
Q3 2013ELAN PLC
CUSIP 284131208
ADR02,043,243+2,043,243$0$31,834,000+$31,834,0002013-11-14
Q3 2013ASTRAZENECA PLC
CUSIP 046353108
SPONSORED ADR0400,000+400,000$0$20,772,000+$20,772,0002013-11-14
Q3 2013AMARIN CORP PLC
CUSIP 023111206
SPONS ADR NEW0300,000+300,000$0$1,896,000+$1,896,0002013-11-14
Q2 2013NATIONAL GRID PLC
CUSIP 636274300
SPON ADR NEW01,000,000+1,000,000$0$56,670,000+$56,670,0002013-08-14
Q2 2013GLAXOSMITHKLINE PLC
CUSIP 37733W105
SPONSORED ADR0325,000+325,000$0$16,240,000+$16,240,0002013-08-14
Q2 2013VODAFONE GROUP PLC NEW
CUSIP 92857W209
SPONS ADR NEW0400,000+400,000$0$11,498,000+$11,498,0002013-08-14

Similar Firms

Firm NameCountry13F ValueHoldings
Baird Financial Group, Inc.United States$64.010B3,212
RENAISSANCE TECHNOLOGIES LLCUnited States$63.930B3,213
Assenagon Asset Management S.A.Luxembourg$65.872B1,095
GQG Partners LLCUnited States$63.092B86
CAISSE DE DEPOT ET PLACEMENT DU QUEBECCanada$62.433B684
Artisan Partners Limited PartnershipUnited States$62.336B334
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUNDCanada$62.212B1,469
ProShare Advisors LLCUnited States$67.536B1,865
MERCER GLOBAL ADVISORS INC /ADVUnited States$67.579B3,217
MITSUBISHI UFJ FINANCIAL GROUP INCUnited States$62.057B1